Dose curve [PK / PD]

posted by Sundar.M – India, 2019-02-15 13:37 (1073 d 23:01 ago) – Posting: # 19925
Views: 1,286

Dear all,

How to choose dose for any PK/PD study (without non-clinical data) in healthy volunteer for Phase-1 trials for already marketed product? Other words, how to choose the proposed dose to detect clinically meaningful differences in PK/PD responses?

Thanks for your help.

Thanks
MSMN

Complete thread:

Activity
 Admin contact
21,849 posts in 4,572 threads, 1,555 registered users;
online 7 (0 registered, 7 guests [including 4 identified bots]).
Forum time: Monday 12:39 CET (Europe/Vienna)

Do, or do not.
There is no ‘try’.    Yoda

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5